The novel therapy of this peptide represents a major breakthrough in the handling of the condition. Different to existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide095464.newsbloger.com/42700547/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment